Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jayadeva

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Expert Opinion on Biological Therapy|December 15, 2020
Similar efficacy, safety, and immunogenicity of the biosimilar BI 695501 and adalimumab reference product in patients with moderate-to-severe chronic plaque psoriasis: results from the randomized Phase III VOLTAIRE-PSO studyAlan Menter, Petr Arenberger, Sigrid Balser, et al.
BMC Genomics|December 9, 2020
Correction to: Molecular signature comprising 11 platelet-genes enables accurate blood-based diagnosis of NSCLCChitrita Goswami, Smriti Chawla, Deepshi Thakral, et al.
Nephrology (Carlton, Vic.)|June 16, 2015
Impact of cinacalcet pre-transplantation on mineral metabolism in renal transplant recipientsAshish K Sharma, Rosemary Masterson, Stephen G Holt, et al.
Advances in Urology|January 28, 2021
Are Technology-Driven Mobile Phone Applications (Apps) the New Currency for Digital Stent Registries and Patient Communication: Prospective Outcomes Using Urostentz AppB M Zeeshan Hameed, Milap J Shah, Nithesh Naik, et al.
Heart, Lung & Circulation|April 12, 2024
Characteristics and Outcomes of a Single-Centre Cohort of Adult Congenital Heart Disease Patients Referred for Heart TransplantPavithra S Jayadeva, Stacey Peters, Su Ling Tee, et al.
British Journal of Clinical Pharmacology|March 10, 2025
Exposure-tumour growth inhibition modelling of brigimadlin using phase I solid tumour data to support phase II dose selectionIda Neldemo, Kamunkhwala Gausi, Céline Sarr, et al.
Rheumatology and Therapy|July 1, 2018
Similar Pharmacokinetics of the Adalimumab (Humira<sup>®</sup>) Biosimilar BI 695501 Whether Administered via Subcutaneous Autoinjector or Prefilled Syringe (VOLTAIRE<sup>®</sup>-AI and VOLTAIRE<sup>®</sup>-TAI): Phase 1, Randomized, Open-Label, Parallel-Group TrialsSteven Ramael, Benjamin Van Hoorick, Renger Tiessen, et al.
Urolithiasis|March 5, 2022
Neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR) and lymphocyte-monocyte ratio (LMR) in predicting systemic inflammatory response syndrome (SIRS) and sepsis after percutaneous nephrolithotomy (PNL)Akshay Kriplani, Shruti Pandit, Arun Chawla, et al.
Thescientificworldjournal|November 6, 2024
A Comparative Assessment of Chromium-Boron Hardfacing Using SMAW and FCAW TechniquesChowda Reddy C, K M Kenchi Reddy, C T Jayadeva, et al.
Human Vaccines & Immunotherapeutics|June 16, 2015
Evaluation of a new syringe presentation of reduced-antigen content diphtheria, tetanus, and acellular pertussis vaccine in healthy adolescents--A single blind randomized trialNoris Pavia-Ruz, Katia Abarca, Alejandro Lepetic, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Expert Opinion on Biological Therapy|December 15, 2020
Similar efficacy, safety, and immunogenicity of the biosimilar BI 695501 and adalimumab reference product in patients with moderate-to-severe chronic plaque psoriasis: results from the randomized Phase III VOLTAIRE-PSO studyAlan Menter, Petr Arenberger, Sigrid Balser, et al.
BMC Genomics|December 9, 2020
Correction to: Molecular signature comprising 11 platelet-genes enables accurate blood-based diagnosis of NSCLCChitrita Goswami, Smriti Chawla, Deepshi Thakral, et al.
Nephrology (Carlton, Vic.)|June 16, 2015
Impact of cinacalcet pre-transplantation on mineral metabolism in renal transplant recipientsAshish K Sharma, Rosemary Masterson, Stephen G Holt, et al.
Advances in Urology|January 28, 2021
Are Technology-Driven Mobile Phone Applications (Apps) the New Currency for Digital Stent Registries and Patient Communication: Prospective Outcomes Using Urostentz AppB M Zeeshan Hameed, Milap J Shah, Nithesh Naik, et al.
Heart, Lung & Circulation|April 12, 2024
Characteristics and Outcomes of a Single-Centre Cohort of Adult Congenital Heart Disease Patients Referred for Heart TransplantPavithra S Jayadeva, Stacey Peters, Su Ling Tee, et al.
British Journal of Clinical Pharmacology|March 10, 2025
Exposure-tumour growth inhibition modelling of brigimadlin using phase I solid tumour data to support phase II dose selectionIda Neldemo, Kamunkhwala Gausi, Céline Sarr, et al.
Rheumatology and Therapy|July 1, 2018
Similar Pharmacokinetics of the Adalimumab (Humira<sup>®</sup>) Biosimilar BI 695501 Whether Administered via Subcutaneous Autoinjector or Prefilled Syringe (VOLTAIRE<sup>®</sup>-AI and VOLTAIRE<sup>®</sup>-TAI): Phase 1, Randomized, Open-Label, Parallel-Group TrialsSteven Ramael, Benjamin Van Hoorick, Renger Tiessen, et al.
Urolithiasis|March 5, 2022
Neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR) and lymphocyte-monocyte ratio (LMR) in predicting systemic inflammatory response syndrome (SIRS) and sepsis after percutaneous nephrolithotomy (PNL)Akshay Kriplani, Shruti Pandit, Arun Chawla, et al.
Thescientificworldjournal|November 6, 2024
A Comparative Assessment of Chromium-Boron Hardfacing Using SMAW and FCAW TechniquesChowda Reddy C, K M Kenchi Reddy, C T Jayadeva, et al.
Human Vaccines & Immunotherapeutics|June 16, 2015
Evaluation of a new syringe presentation of reduced-antigen content diphtheria, tetanus, and acellular pertussis vaccine in healthy adolescents--A single blind randomized trialNoris Pavia-Ruz, Katia Abarca, Alejandro Lepetic, et al.
Pageof 10